ag 1879 and Thyroid Neoplasms studies

ag 1879 and Thyroid Neoplasms

ag 1879 has been researched along with Thyroid Neoplasms in 5 studies

3-(4-chlorophenyl)-1-(1,1-dimethylethyl)-1H-pyrazolo(3,4-d)pyrimidin-4-amine: Fyn kinase inhibitor

Thyroid Neoplasms: Tumors or cancer of the THYROID GLAND.

Research Excerpts

Excerpt	Relevance	Reference
"Papillary thyroid carcinoma is the most common thyroid malignancy."	1.40	Src inhibitors in suppression of papillary thyroid carcinoma growth. ( Chen, Y; Clayman, GL; Frederick, MJ; Gallick, GE; Henderson, YC; Lai, SY; Ryu, J; Toro-Serra, R; Zhou, G, 2014)

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	4 (80.00)	29.6817
2010's	1 (20.00)	24.3611
2020's	0 (0.00)	2.80

Timeframe

Studies, this research(%)

All Research%

pre-1990

0 (0.00)

18.7374

1990's

0 (0.00)

18.2507

2000's

4 (80.00)

29.6817

2010's

1 (20.00)

24.3611

2020's

0 (0.00)

2.80

Authors

Authors	Studies
Henderson, YC	1
Toro-Serra, R	1
Chen, Y	1
Ryu, J	1
Frederick, MJ	1
Zhou, G	1
Gallick, GE	1
Lai, SY	1
Clayman, GL	1
Carlomagno, F	2
Vitagliano, D	1
Guida, T	2
Basolo, F	1
Castellone, MD	1
Melillo, RM	1
Fusco, A	2
Santoro, M	2
Carniti, C	1
Perego, C	1
Mondellini, P	1
Pierotti, MA	1
Bongarzone, I	1
Anaganti, S	1
Vecchio, G	1
Ryan, AJ	1
Billaud, M	1
Liu, Z	1
Falola, J	1
Zhu, X	1
Gu, Y	1
Kim, LT	1
Sarosi, GA	1
Anthony, T	1
Nwariaku, FE	1

Studies

Henderson, YC

Toro-Serra, R

Chen, Y

Ryu, J

Frederick, MJ

Zhou, G

Gallick, GE

Lai, SY

Clayman, GL

Carlomagno, F

Vitagliano, D

Guida, T

Basolo, F

Castellone, MD

Melillo, RM

Fusco, A

Santoro, M

Carniti, C

Perego, C

Mondellini, P

Pierotti, MA

Bongarzone, I

Anaganti, S

Vecchio, G

Ryan, AJ

Billaud, M

Liu, Z

Falola, J

Zhu, X

Gu, Y

Kim, LT

Sarosi, GA

Anthony, T

Nwariaku, FE

Other Studies

5 other studies available for ag 1879 and Thyroid Neoplasms

Article	Year
Src inhibitors in suppression of papillary thyroid carcinoma growth. Head & neck, 2014, Volume: 36, Issue:3 Topics: Animals; Carcinoma; Carcinoma, Papillary; Cell Proliferation; Dasatinib; Disease Models, Animal; Ind	2014
Efficient inhibition of RET/papillary thyroid carcinoma oncogenic kinases by 4-amino-5-(4-chloro-phenyl)-7-(t-butyl)pyrazolo[3,4-d]pyrimidine (PP2). The Journal of clinical endocrinology and metabolism, 2003, Volume: 88, Issue:4 Topics: 3T3 Cells; Animals; Carcinoma, Papillary; Cell Line, Transformed; Drosophila Proteins; Enzyme Activa	2003
PP1 inhibitor induces degradation of RETMEN2A and RETMEN2B oncoproteins through proteosomal targeting. Cancer research, 2003, May-01, Volume: 63, Issue:9 Topics: 3T3 Cells; Animals; Enzyme Inhibitors; Humans; Mice; Multiple Endocrine Neoplasia Type 2a; Multiple	2003
Disease associated mutations at valine 804 in the RET receptor tyrosine kinase confer resistance to selective kinase inhibitors. Oncogene, 2004, Aug-12, Volume: 23, Issue:36 Topics: Carcinoma, Medullary; Catalytic Domain; Cell Line; Drug Resistance; Enzyme Inhibitors; Mitogens; Pip	2004
Antiproliferative effects of Src inhibition on medullary thyroid cancer. The Journal of clinical endocrinology and metabolism, 2004, Volume: 89, Issue:7 Topics: Apoptosis; Carcinoma, Medullary; Cell Division; Cell Line, Tumor; CSK Tyrosine-Protein Kinase; Enzym	2004

Article

Year

Src inhibitors in suppression of papillary thyroid carcinoma growth.

Head & neck, 2014, Volume: 36, Issue:3

Topics: Animals; Carcinoma; Carcinoma, Papillary; Cell Proliferation; Dasatinib; Disease Models, Animal; Ind

2014

Efficient inhibition of RET/papillary thyroid carcinoma oncogenic kinases by 4-amino-5-(4-chloro-phenyl)-7-(t-butyl)pyrazolo[3,4-d]pyrimidine (PP2).

The Journal of clinical endocrinology and metabolism, 2003, Volume: 88, Issue:4

Topics: 3T3 Cells; Animals; Carcinoma, Papillary; Cell Line, Transformed; Drosophila Proteins; Enzyme Activa

2003

PP1 inhibitor induces degradation of RETMEN2A and RETMEN2B oncoproteins through proteosomal targeting.

Cancer research, 2003, May-01, Volume: 63, Issue:9

Topics: 3T3 Cells; Animals; Enzyme Inhibitors; Humans; Mice; Multiple Endocrine Neoplasia Type 2a; Multiple

2003

Disease associated mutations at valine 804 in the RET receptor tyrosine kinase confer resistance to selective kinase inhibitors.

Oncogene, 2004, Aug-12, Volume: 23, Issue:36

Topics: Carcinoma, Medullary; Catalytic Domain; Cell Line; Drug Resistance; Enzyme Inhibitors; Mitogens; Pip

2004

Antiproliferative effects of Src inhibition on medullary thyroid cancer.

The Journal of clinical endocrinology and metabolism, 2004, Volume: 89, Issue:7

Topics: Apoptosis; Carcinoma, Medullary; Cell Division; Cell Line, Tumor; CSK Tyrosine-Protein Kinase; Enzym

2004